CoChat

Insulin-Like Growth Factor 2 in Development and Disease: A Mini-Review

The DOI matches its Crossref record; 35 of the 35 references it cites were found in a registry or an index.

Abstract

Background: Insulin-like growth factor 2 (IGF2) is a protein hormone known to regulate cell proliferation, growth, migration, differentiation and survival. The gene is parentally imprinted in the sense that transcripts are almost exclusively derived from the paternal allele. Loss of imprinting of the IGF2 gene is a recurrent observation in growth disorders that combine overgrowth with a variety of malignant tumours. Moreover, IGF2 has been proposed to play a role in the development of a variety of seemingly unrelated cancers that play an important role in geriatric medicine, e.g. breast cancer, colon cancer and lung cancer. Finally, IGF2 has been implicated in cardiovascular disease, since, for example, IGF2 has been shown to influence the size of atherosclerotic lesions. Objective: To summarize current knowledge about IGF2, its interactions with binding proteins and receptors and connections with key diseases. Methods: The contents of this paper were based on reviews of existing literature within the field. Results: There is a substantial amount of research linking IGF2 to growth disorders, cancer and to a much lesser degree cardiovascular disease. Some of the studies on IGF2 and tumour growth have yielded conflicting results, for instance regarding its effect on apoptosis. Conclusion: Today, our knowledge on how IGF2 is composed and interacts with receptors has come a long way. However, there is comparatively little information on how IGF2 affects tumour growth and cardiovascular diseases such as atherosclerosis. Thus, further research will be needed to elucidate the impact of IGF2 on key diseases.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1159/000343995

Cites

35 of 35 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 35 references

Cited by

See all 260

Metadata

Authors
Bergman, D., Halje, M., Nordin, M., & Engström, W.
Affiliations
Swedish University of Agricultural Sciences (SE)
Venue
Gerontology
Publisher
S. Karger AG
Published
2012-12-20
Volume
59
Issue
3
Pages
240-249
ISSN
  • 0304-324X (ISSN-L)
  • 1423-0003
OpenAlex
W1976143235
Cited by
260
References
35
Citations by year
2026: 4 · 2025: 13 · 2024: 27 · 2023: 21 · 2022: 27 · 2021: 35 · 2020: 37 · 2019: 13 · 2018: 15 · 2017: 15 · 2016: 17 · 2015: 17 · 2014: 15 · 2013: 3
FWCI
1.54
Type
journal article
Language
en
Open access
closed
Licence
Locations
  • Gerontology (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Growth Hormone and Insulin-like Growth Factors
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genetic Syndromes and Imprinting
  • Health Sciences › Medicine › Pediatrics, Perinatology and Child Health › Birth, Development, and Health
Keywords
insulin-like growth factor II, genomic imprinting, loss of imprinting, overgrowth syndromes, cancer, breast cancer, colon cancer, lung cancer, cardiovascular disease, atherosclerosis, IGF-II receptor, apoptosis, tumor growth, geriatrics
MeSH terms
Animals, Cardiovascular Diseases, Disease, Female, Humans, Insulin-Like Growth Factor II, Male, Neoplasms, Protein Processing, Post-Translational, Receptor, Insulin, Signal Transduction, Receptor, IGF Type 1, Receptor, IGF Type 2, Genomic Imprinting, Insulin-Like Growth Factor Binding Proteins, Growth and Development, Mice

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Insulin-Like Growth Factor 2 in Development and Disease: A Mini-Review. https://app.cochat.ai/papers/10.1159/000343995
The paper
Bergman, D., Halje, M., Nordin, M., & Engström, W. (2013). Insulin-Like Growth Factor 2 in Development and Disease: A Mini-Review. Gerontology. https://doi.org/10.1159/000343995

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.